We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image
  • Published In : Jul 2023
  • Code : CMI3793
  • Pages :178
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Europe Gelatin and Bone Glue Market is estimated to be valued at US$ 241.84 Mn in 2023 and is expected to exhibit a CAGR of 6.1%  during the forecast period (2023-2030).

Analysts’ Views on Europe Gelatin and Bone Glue Market:

The Europe gelatin and bone Glue market plays a crucial role in various sectors such as pharmaceuticals, food and beverages, healthcare, and cosmetics. Gelatin and bone glue are sought after for their unique properties and diverse applications. These include their use in pharmaceutical formulations, surgical procedures, and as ingredients in collagen-rich products. Despite challenges posed by the rise of plant-based alternatives and regulatory compliance, the European market continues to exhibit resilience and growth. With increasing demand and a focus on innovation, the gelatin and bone glue market in Europe remains dynamic and poised for further expansion.

Figure 1. Europe gelatin and bone Glue market Share (%), By Product Type, 2023

EUROPE GELATIN AND BONE GLUE MARKET

To learn more about this report, request a free sample copy

Europe Gelatin and Bone Glue Market– Driver

The Europe gelatin and bone glue market is primarily driven by the growing demand from the pharmaceutical industry, as well as the increasing popularity of gelatin and bone glue in the food and beverages, healthcare, and cosmetics sectors.

The Europe gelatin and bone glue market is experiencing growth due to the rising prevalence of bone disorders and the increasing adoption of gelatin and bone glue in sports injuries. These products provide effective solutions for bone healing and offer alternatives to invasive procedures. With advancements in technology, the market is expected to continue expanding in Europe.

On May 20, 2021, Rousselot, a brand of Darling Ingredients, and the global leader of collagen-based solutions1 expands its range of purified, pharmaceutical grade, modified gelatins with the launch of X-Pure GelDAT– Gelatin Desaminotyrosine. Created in response to customer’s demand to overcome the barriers encountered in clinic translation, this is the first, readily available biomaterial of its kind. X-Pure GelDAT offers guaranteed purity and consistency at scale, vital to the successful development of biomedical applications used in the human body.

Figure 2. Europe gelatin and bone Glue market Share (%), By country, 2023

EUROPE GELATIN AND BONE GLUE MARKET

To learn more about this report, request a free sample copy

Europe Gelatin and Bone Glue Market- Country Analysis

The gelatin and bone glue market in Europe is experiencing significant growth across various regions. Factors driving this growth include increasing consumer demand for convenience, rising interest in functional foods, and a focus on healthier food choices. Western Europe, Eastern Europe, the Nordic countries, and Southern Europe all contribute to the expansion of the market.

Europe Gelatin and Bone Glue Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems regarding transportation of drugs from one place to another.

However ,the COVID-19 pandemic had a dual impact on the gelatin and bone glue market in Europe. On one hand, there was a decline in demand due to reduced elective surgeries and disruptions in the supply chain. On the other hand, there was a significant increase in the demand for both hard and soft gel capsules, primarily driven by the pharmaceutical sector. As consumers became more focused on maintaining their health, there was a surge in the demand for supplements. This, in turn, prompted gelatin manufacturers to ramp up their production of capsules to meet the growing needs. For instance, in October 2020, Lonza recently unveiled plans for a substantial USD 93 million investment in its Capsules and Health Ingredients (CHI) division, aiming to bolster its gelatin production capacity by an additional 30 billion capsules per year. Moreover, the gelatin market's success can be attributed to the rising consumer inclination towards functional food and beverages during the outbreak. The surge in interest surrounding health and well-being has fueled a growing demand for products offering specific health benefits.

Europe Gelatin and Bone Glue Market Report Coverage

Report Coverage Details
Base Year: 2022 Market Size in 2023: US$ 241.8 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 to 2030
Forecast Period 2023 to 2030 CAGR: 6.1% 2030 Value Projection: US$ 366.6 Mn
Geographies covered:
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Segments covered:
  • By Product Type: Gelatin(Acidic Pretreatment, Alkali Pretreatment) Bone Glues(Synthetic Bone Glues, Natural Bone Glues)
  • By Application: Arthroplasty, Sports Injury, Spine Surgery, Trauma, Others
  • By End User: Hospital, Specialty Clinics, Ambulatory Surgical Centers
Companies covered:

Johnson & Johnson, Baxter International Inc., CryoLife, Inc., Becton, Dickinson and Company, Luna Innovations Incorporated, B. Braun Melsungen AG, Cohera Medical Inc., Integra LifeSciences Corporation, Tissuemed Ltd., and Chemence Medical, Inc.

Growth Drivers:
  • Rising prevalence of bone disorders and the increasing adoption of gelatin and bone glue in sports injuries
Restraints & Challenges:
  • Challenges in cemented arthroplasty and their impact on the market

Global Europe Gelatin and Bone Glue Market- Segmentation

The Europe Gelatin and Bone Glue Market is segmented into by product type ,by application,by end user, and by country.

By Product, the market is segmented into Gelatin (Acidic Pretreatment and Alkali Pretreatment) and Bone Glues (Synthetic Bone Glues and Natural Bone Glues). In Europe, gelatin derived from acidic pretreatment is the dominant type in the gelatin segment, while natural bone glues are preferred in the bone glue segment for their biocompatibility and adhesive properties.

By Application, the Europe gelatin and bone Glue market is segmented into various applications, including arthroplasty, sports injury, spine surgery, trauma, and others. Arthroplasty and spine surgery emerge as the dominant applications in the Europe gelatin and bone glue market, driven by the high demand for joint replacements and interventions for spinal conditions. While sports injuries and trauma also hold significance, arthroplasty and spine surgery play a prominent role in shaping the market dynamics in the region.

By End User, the market is segmented into hospitals, Ambulatory surgical centers, speciality clinics. Hospitals have the highest dominance in the gelatin and bone glue market, followed by specialty clinics and ambulatory surgical centers. This is due to hospitals' larger scale, broader range of procedures, and higher demand for gelatin and bone glue products. Specialty clinics have a more specialized focus and relatively smaller demand, while ambulatory surgical centers have limited capacity and are utilized for less complex surgeries.

By country, in Europe, the gelatin and bone glue market is dominated by highly developed and prominent countries such as Germany, Italy, France, Spain, and the U.K. Germany stands out with its strong manufacturing sector and expertise in pharmaceuticals, medical devices, and chemicals. Italy is known for its craftsmanship and a thriving pharmaceutical industry. France and Spain also have strong pharmaceutical industries, making significant contributions to the market. However, the market position of the United Kingdom has become uncertain due to its withdrawal from the European Union.The rest of Europe comprises countries with varying levels of market presence. Overall, these nations play a crucial role in shaping and driving the gelatin and bone glue market in Europe.

Europe Gelatin and Bone Glue Market- Cross Sectional Analysis

Among Application type, Arthroplasty and spine surgery are anticipated to emerge as the dominant applications in Germany. Due to high demand for joint replacements and interventions for spinal condition using bone glue. For instance, according to an article published by PubMed in September 2021, a study was conducted in Germany, and it was reported that half of the elderly population in Germany experiences spinal cord injury and does require surgery for its treatment using bone glue . Hence, it is a major factor, thereby driving the growth of the market.

Europe Gelatin and Bone Glue Market: Key Developments

On March 12, 2023, Baxter pvt. ltd India, a subsidiary of Baxter International, has announcd its plans to introduce more innovative products to the Indian market in 2023 and beyond. With a strong presence in India for over 25 years, Baxter operates a manufacturing facility in Ahmedabad and has research and development centers in Bengaluru and Ahmedabad. The company focuses on treating chronic kidney disease and offers a broad portfolio of critical care, nutrition, renal, hospital, surgical, and pharmaceutical products. Baxter India aims to invest in the country, diversify its business portfolio, and expand its footprint to meet the evolving healthcare needs in India.

In November 2020, Rousselot, Rousselot is a leading global manufacturer of gelatin and collagen peptides, providing innovative solutions for the food, pharmaceutical, and health industries. With a strong commitment to quality and sustainability, Rousselot continues to drive advancements in bioactive ingredients and functional proteins. Rousselot introduced gummy caps, a versatile delivery format combining capsules, soft gels, and gummies, under its SiMoGel brand for nutraceutical and pharmaceutical applications.

On June 12, 2023, Becton, Dickinson and Company launched the BD FACSDuet™ Premium System. This automated instrument revolutionizes clinical flow cytometry diagnostics by streamlining sample preparation and enabling a "walkaway" workflow solution. By reducing manual steps and promoting standardization, it empowers healthcare professionals to focus on sample analysis and interpretation.

On September 2, 2020, Azelis, a global distributor of specialty chemicals and ingredients, entered into an exclusive distribution agreement with GELITA, a renowned supplier of collagen proteins and collagen-based solutions. Under this agreement, Azelis will distribute GELITA's gelatin range in France, specifically targeting the pharmaceutical and nutraceutical industries. This strategic partnership expands Azelis' product portfolio, leveraging their market position and expertise to offer innovative solutions. Simultaneously, the agreement supports GELITA's sales efforts in the French market, benefiting from Azelis' extensive distribution network and strong presence in the region.

Global Europe Gelatin and Bone Glue Market- Key Trends

Rising demand for gelatin and bone glue driven by functional food boom and health consciousness

The increasing demand for convenience among consumers has surged in recent years due to their busy lifestyles and ever-changing preferences in food and beverage choices. As functional food gains popularity, individuals are placing greater emphasis on food quality and the health benefits associated with different food items. Consequently, there is a growing inclination towards consuming healthier foods, which in turn drives the expansion of the gelatin market.

Europe Gelatin and Bone Glue Market: Restraint

Challenges in Cemented Arthroplasty and its Impact on the Market

The gelatin and bone glue market in Europe faces hindrances due to complications associated with cemented arthroplasty procedures. These challenges include the risk of inflammation in surrounding soft tissues and cement breakdown, which may necessitate additional arthroplasty surgery. Furthermore, the occurrence of bone cement implantation syndrome (BCIS) can deter the adoption of cemented joint arthroplasty. These complications pose significant concerns, potentially impacting the growth and acceptance of cemented arthroplasty in the market.

March 8, 2023 - A recent study presented at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting and published in The Journal of Arthroplasty in October 2022 has highlighted the increased fracture risk associated with using cementless implants in total hip replacement surgeries for femoral neck fractures. The retrospective study, analyzing cases from 2006 to 2020, revealed a higher rate of subsequent fractures and revision surgeries when cementless prosthesis was utilized. The findings underscore the importance of considering cemented fixation to minimize complications in these procedures, particularly in patients with weaker bone quality.

Europe Gelatin and Bone Glue Market- Key Players

Major players operating in the Europe gelatin and bone Glue market include Johnson & Johnson, Baxter International Inc., CryoLife, Inc., Becton, Dickinson and Company, Luna Innovations Incorporated, B. Braun Melsungen AG, Cohera Medical, Inc., Integra LifeSciences Corporation, Tissuemed Ltd., and Chemence Medical, Inc.

*Definition: The gelatin and bone glue market involves the production, distribution, and sale of gelatin and bone glue products. Gelatin is derived from animal tissues and serves as a gelling agent and stabilizer in food, pharmaceuticals, and cosmetics. Bone glue, also derived from animal bones, is used as an adhesive in medical and surgical procedures for joining and repairing bones and tissues.

Frequently Asked Questions

The Europe gelatin and bone Glue market is expected to value US$ 241.84 million in 2023 and is expected to exhibit a CAGR of 6.1% between 2023 and 2030.

Rising prevalence of bone disorders and increasing adoption of gelatin and bone glue in sports injuries is expected to drive the market growth.

In Europe, gelatin derived from acidic pretreatment is the dominant type in the gelatin segment, while natural bone glues are preferred in the bone glue segment for their biocompatibility.

Challenges in Cemented Arthroplasty and its Impact on the Market is expected to hinder the Europe gelatin and bone Glue market growth  over the forecast period.

Major players operating in the market including Johnson & Johnson, Baxter International Inc., CryoLife, Inc., Becton, Dickinson and Company, Luna Innovations Incorporated, B. Braun Melsungen AG, Cohera Medical, Inc., Integra LifeSciences Corporation, Tissuemed Ltd., and Chemence Medical, Inc.

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Reliability and Reputation

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Reliability and Reputation

27001:2022

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.